title: Approving Drugs Based on Early Stage Data - How Phase II Trial Data Correlates with Phase III Outcomes. Case Study: NSCLC.
authors.affiliation: HERON Commercialization, London, UK.
authors.forename: R
authors.initials: R
authors.lastname: Macaulay
authors.affiliation: HERON Commercialization, London, UK.
authors.forename: H
authors.initials: H
authors.lastname: Tan